132 related articles for article (PubMed ID: 36928467)
1. Open Thy Lattice Osteoclast, Resorb me!
Bakiri L
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36928467
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.
Zhu L; Tang Y; Li XY; Kerk SA; Lyssiotis CA; Sun X; Wang Z; Cho JS; Ma J; Weiss SJ
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36880731
[TBL] [Abstract][Full Text] [Related]
3. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.
Kittaka M; Mayahara K; Mukai T; Yoshimoto T; Yoshitaka T; Gorski JP; Ueki Y
J Bone Miner Res; 2018 Jan; 33(1):167-181. PubMed ID: 28914985
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.
Zhu L; Tang Y; Li XY; Keller ET; Yang J; Cho JS; Feinberg TY; Weiss SJ
Sci Transl Med; 2020 Feb; 12(529):. PubMed ID: 32024800
[TBL] [Abstract][Full Text] [Related]
5. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
[TBL] [Abstract][Full Text] [Related]
6. Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
Löfvall H; Newbould H; Karsdal MA; Dziegiel MH; Richter J; Henriksen K; Thudium CS
Arthritis Res Ther; 2018 Apr; 20(1):67. PubMed ID: 29636095
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
8. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
9. Microcracks and osteoclast resorption activity in vitro.
Rumpler M; Würger T; Roschger P; Zwettler E; Peterlik H; Fratzl P; Klaushofer K
Calcif Tissue Int; 2012 Mar; 90(3):230-8. PubMed ID: 22271249
[TBL] [Abstract][Full Text] [Related]
10. Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts.
Chellaiah MA; Ma T
Biomed Res Int; 2013; 2013():302392. PubMed ID: 23984338
[TBL] [Abstract][Full Text] [Related]
11. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
12. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
13. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment.
Delaissé JM; Eeckhout Y; Neff L; François-Gillet C; Henriet P; Su Y; Vaes G; Baron R
J Cell Sci; 1993 Dec; 106 ( Pt 4)():1071-82. PubMed ID: 8126092
[TBL] [Abstract][Full Text] [Related]
14. The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction.
Ishida S; Yamane S; Nakano S; Yanagimoto T; Hanamoto Y; Maeda-Tanimura M; Toyosaki-Maeda T; Ishizaki J; Matsuo Y; Fukui N; Itoh T; Ochi T; Suzuki R
Immunology; 2009 Sep; 128(1 Suppl):e315-24. PubMed ID: 19019090
[TBL] [Abstract][Full Text] [Related]
15. Steering the osteoclast through the demineralization-collagenolysis balance.
Søe K; Merrild DM; Delaissé JM
Bone; 2013 Sep; 56(1):191-8. PubMed ID: 23777960
[TBL] [Abstract][Full Text] [Related]
16. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.
Parikka V; Lehenkari P; Sassi ML; Halleen J; Risteli J; Härkönen P; Väänänen HK
Endocrinology; 2001 Dec; 142(12):5371-8. PubMed ID: 11713237
[TBL] [Abstract][Full Text] [Related]
17. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
[TBL] [Abstract][Full Text] [Related]
18. Novel Insights into Osteoclast Energy Metabolism.
Ledesma-Colunga MG; Passin V; Lademann F; Hofbauer LC; Rauner M
Curr Osteoporos Rep; 2023 Dec; 21(6):660-669. PubMed ID: 37816910
[TBL] [Abstract][Full Text] [Related]
19. A Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in Culture.
Pirapaharan DC; Søe K; Panwar P; Madsen JS; Bergmann ML; Overgaard M; Brömme D; Delaisse JM
Calcif Tissue Int; 2019 Jan; 104(1):92-101. PubMed ID: 30194476
[TBL] [Abstract][Full Text] [Related]
20. Centrosome clustering control in osteoclasts through CCR5-mediated signaling.
Lee JW; Lee IH; Watanabe H; Liu Y; Sawada K; Maekawa M; Uehara S; Kobayashi Y; Imai Y; Kong SW; Iimura T
Sci Rep; 2023 Nov; 13(1):20813. PubMed ID: 38012303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
